Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth by Samuel, Michael S et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Actomyosin-mediated cellular tension drives increased tissue
stiffness and -catenin activation to induce epidermal hyperplasia
and tumor growth
Citation for published version:
Samuel, MS, Lopez, JI, McGhee, EJ, Croft, DR, Strachan, D, Timpson, P, Munro, J, Schröder, E, Zhou, J,
Brunton, VG, Barker, N, Clevers, H, Sansom, OJ, Anderson, KI, Weaver, VM & Olson, MF 2011,
'Actomyosin-mediated cellular tension drives increased tissue stiffness and -catenin activation to induce
epidermal hyperplasia and tumor growth' Cancer cell, vol. 19, no. 6, pp. 776-91. DOI:
10.1016/j.ccr.2011.05.008
Digital Object Identifier (DOI):
10.1016/j.ccr.2011.05.008
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Cancer cell
Publisher Rights Statement:
NIH public access author manuscript
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce interfollicular epidermal hyperplasia and tumor growth
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115541/#FN3[02/08/2013 11:46:42]
Cancer Cell.  Author manuscript; available in PMC 2012 June 14.
Published in final edited form as:
Cancer Cell.  2011 June 14; 19(6): 776–791.
doi:  10.1016/j.ccr.2011.05.008
PMCID: PMC3115541
NIHMSID: NIHMS297093
Actomyosin-mediated cellular tension drives increased tissue stiffness and β-
catenin activation to induce interfollicular epidermal hyperplasia and tumor
growth
Michael S Samuel,  Jose I Lopez,  Ewan J McGhee,  Daniel R Croft,  David Strachan,  Paul Timpson,  June
Munro,  Ewald Schröder,  Jing Zhou,  Valerie G Brunton,  Nick Barker,  Hans Clevers,  Owen J Sansom,  Kurt I
Anderson,  Valerie M Weaver,  and Michael F Olson
 Beatson Institute for Cancer Research, Glasgow G61 1BD, UK
 Department of Surgery, UCSF, San Francisco, CA 94143, USA
 Cancer Research Technology, WIBR, London WC1E 6BT, UK
 Edinburgh Cancer Research Centre, Edinburgh EH4 2X9, UK
 Hubrecht Institute, Uppsalalaan 8, 3584CT Utrecht, Netherlands
 Corresponding author: MF Olson, Tel: +44 141 330 3654, Email: m.olson@beatson.gla.ac.uk
Present address: Centre for Cancer Biology, Frome Road, Adelaide 5000, Australia
Copyright notice and Disclaimer
Publisher's Disclaimer
SUMMARY
Tumors and associated stroma manifest mechanical properties that promote cancer. Mechanosensation
of tissue stiffness activates the Rho/ROCK pathway to increase actomyosin-mediated cellular tension to
re-establish force equilibrium. To determine how actomyosin tension affects tissue homeostasis and
tumor development, we expressed conditionally-active ROCK2 in mouse skin. ROCK activation elevated
tissue stiffness via increased collagen. β-catenin, a key element of mechanotranscription pathways, was
stabilized by ROCK activation leading to nuclear accumulation, transcriptional activation and
consequent hyperproliferation and skin thickening. Inhibiting actomyosin contractility by blocking
LIMK or myosin ATPase attenuated these responses, as did FAK inhibition. Tumor number, growth and
progression were increased by ROCK activation, while ROCK blockade was inhibitory, implicating
actomyosin-mediated cellular tension and consequent collagen deposition as significant tumor
promoters.
Introduction
Tumors grow in complex environments in which external factors, such as tissue rheology (Butcher et
al., 2009), influence growth and progression. Despite the association of tissue stiffness with cancer
being so well established that palpation and elastography are diagnostic procedures for some tumors,
the mechanisms that translate mechanosensation of external conditions to the induction of tumor-
promoting responses remain poorly understood.
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Rho GTPases act as network hubs that transduce signals from the extracellular environment to proteins
that mediate biological responses (Parsons et al., 2010). ROCK1 and ROCK2 are essential for RhoA and
RhoC-initiated actomyosin contractility through phosphorylation of substrates including LIM kinases
(LIMK), myosin regulatory light chains (MLC2) and the myosin-binding subunit of the MLC
phosphatase (MYPT), which facilitates cell movement and contributes to cancer metastasis (Olson and
Sahai, 2009). Rho activation was first found after growth factor receptor stimulation (Ridley and Hall,
1992), but Rho proteins respond to additional inputs, including external force, to affect cytoskeletal
structure and function (Parsons et al., 2010). External tensile force results in compensatory Rho/ROCK
activation, to increase cellular tension and reestablish force equilibrium (Wozniak et al., 2003; Zhao et
al., 2007). At the same time, internal cellular tension remains in equilibrium with the external
microenvironment through the reorganization, modification and/or synthesis of extracellular matrix
(ECM) proteins (Chiquet et al., 2009; Wu et al., 2007). In some pathological contexts, force
equilibration may not be achieved, resulting in a mechanical autocrine loop that drives rheological
changes and consequent tissue stiffness.
Skin is a mechanically responsive tissue (Silver et al., 2003), which forms a barrier that protects against
damaging environmental stresses. Net tension in the skin is a balance between external collagen fibrils
and internal actomyosin cellular tension (Silver et al., 2003). To maintain barrier integrity, cells are
constantly renewed in a tightly controlled process termed epidermal homeostasis (Blanpain and Fuchs,
2009). Squamous cell carcinoma (SCC) develops in keratinocytes that have differentiated and moved
from the basal layer, and is the second most common skin cancer (Xie, 2008). Rho and ROCK
signaling are associated with SCC (Jiang et al., 2010; Lefort et al., 2007; Wang et al., 2009), although
details of how Rho/ROCK may promote SCC are lacking.
In this current study, we investigated how actomyosin cellular tension influences tissue rheology,
epidermal homeostasis and tumor growth and progression.
Results
ROCK activation increases tissue stiffness
To investigate how cellular tension affects tissue homeostasis and cancer, we created K14-ROCK:ER
mice (Samuel et al., 2009a) that express a chimeric protein (ROCK:ER) consisting of the human
ROCK2 kinase domain fused to mutant 17β-estradiol-insensitive estrogen receptor (ER) hormone
binding domain (HBD) (Littlewood et al., 1995) and enhanced green fluorescent protein (EGFP) under
the control of the K14 promoter (Figures S1A, B). Upon HBD binding of tamoxifen or 4-
hydroxytamoxifen (4HT), ROCK:ER is activated and phosphorylates physiological substrates leading to
actomyosin-mediated contractility (Samuel et al., 2009a). K14-ROCK:ER and a control kinase-dead
(KD) version (K14-KD:ER) were each targeted to the Hprt locus, leading to expression ~15% of
endogenous ROCK2 (Samuel et al., 2009a). Consistent with previous results (Samuel et al., 2009a),
4HT treatment of K14-ROCK:ER mouse skin increased Mlc2 phosphorylation, but not in K14-KD:ER or
Wild-type (WT) control mice (Figure 1A). Thr696 phosphorylation of the myosin binding subunit of the
Mlc phosphatase (pMypt1), which inhibits Mlc dephosphorylation (Feng et al., 1999), was also
increased by 4HT specifically in K14-ROCK:ER mouse skin (Figure 1A).
To determine how ROCK activation and consequent cellular tension affected tissue rheology, K14-
ROCK:ER and WT skin dorsal skin was given 5 daily 4HT treatments, then subjected to rheological
analysis by atomic force microscopy (AFM). Compared to WT skin, ROCK activated skin showed an
AFM force map skewed towards high kPa values and significant increase in Young’s modulus,
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demonstrating increased tissue stiffness (Figure 1B, C). When viewed through orthogonal polarizing
filters, ROCK activated skin also had increased picrosirius red fluorescence, indicating increased
collagen fiber diameters (Figure 1B, C). Accordingly, second harmonic generation (SHG) analysis of
4HT treated K14-ROCK:ER skin showed increased collagen density and expanded distribution from the
epidermal surface to greater depths compared to WT (Figures 1D, E, Movies S1, S2 and S3), confirming
previous reports of correlations between optical and mechanical properties of collagen in vivo (Raub et
al., 2010; Raub et al., 2008). These results show that ROCK-induced actomyosin cellular tension is
associated with increased collagen fiber diameter and elevated collagen deposition over a broader
distribution. Therefore, internal cellular tension drives significant tissue-level compensatory responses.
ROCK activation drives epidermal proliferation and skin thickening
Within 5 days of daily 4HT treatment, ROCK activated skin was significantly thicker than K14-KD:ER
and WT skin (Figure 2A, S2A), associated with interfollicular epidermal expansion by several cell
layers. ROCK-induced epidermal thickening was associated with a significant doubling in BrdU-positive
proliferating basal keratinocytes relative to control K14-KD:ER or WT mice (Figure 2B, S2B). K14-
ROCK:ER keratinocytes cultured in 4HT grew in soft agar, yielding 2.5-fold as many anchorage-
independent colonies as K14-KD:ER keratinocytes (Figure 2C). Y27632 treatment abolished this effect,
showing ROCK dependence of the increased anchorage-independent growth.
ROCK-induced skin thickening was associated with expansion of the suprabasal interfollicular
epidermal cell layer expressing cytokeratin 1 (K1) and ectopic expression of the follicular cytokeratin 6
(K6) by immunofluorescence and FACS analyses (Figure 2D, S2B, S2C). K14-KD:ER and WT control
mice had no skin thickening and retained normal K1 and K6 expression following 4HT treatment (
Figure 2D, S2D). Inhibition of lysyl oxidase (Lox) with β-aminopropionitrile (BAPN) to reduce collagen
fibril cross-linking in rigid matrices (Levental et al., 2009) reversed K6 induction (Figure 2D). K6
expression, which is commonly observed in SCC (Haass et al., 2006; Khayyata et al., 2009), has been
associated with either epidermal hyperplasia or inflammation (Kopan and Fuchs, 1989; Stoler et al.,
1988; Weiss et al., 1984). However, inflammatory infiltrate as observed in DMBA/TPA papillomas was
not evident in ROCK activated skin (Figure S2E). The observations that ROCK activation caused skin
thickening, increased proliferation, K6 expression and anchorage independent growth indicate that
sustained actomyosin-mediated cellular tension has a pro-proliferative role within the epidermis.
ROCK activates β-catenin and elevates transcriptional target expression
β-catenin has important roles in epidermal homeostasis and tumorigenesis, regulating progenitor cell
proliferation through Tcf/Lef target gene transcription (Lo Celso et al., 2004; Malanchi et al., 2008;
Nguyen et al., 2009; Zhu and Watt, 1999). β-catenin is also a central element in transcription pathways
responsive to mechanical stimulation (Arnsdorf et al., 2009; Sen et al., 2009), suggesting that β-catenin
might mediate responses to elevated collagen and tissue stiffness. ROCK activation within the epidermis
caused significant increases in expression of the Tcf/Lef target genes CD44 (Wielenga et al., 1999),
Cyclin D1 (Shtutman et al., 1999; Tetsu and McCormick, 1999) and Lgr5 (Jaks et al., 2008) at mRNA
and protein levels (Figure 3A, 3B, 3C) relative to K14-KD:ER and WT epidermis. CD44 and Cyclin D1
mRNA were also upregulated in primary cultured keratinocytes by ROCK activation (Figure S3).
To confirm Tcf/Lef transcriptional activation, K14-ROCK:ER and K14-KD:ER mice were crossed with
TOPGAL reporter mice, which express β-galactosidase under the control of an engineered TOP
promoter containing 3 tandem Tcf/Lef consensus binding sites, (DasGupta and Fuchs, 1999). TOPGAL;
K14-ROCK:ER mice expressed β-galactosidase throughout the interfollicular epidermis upon 4HT
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treatment, unlike TOPGAL; K14-KD:ER mice (Figure 3D). Luciferase-based Tcf/Lef (TOPFlash) assays
of cultured primary keratinocytes also showed significant 4HT-induced Tcf/Lef transcriptional activity
in ROCK:ER expressing cells, comparable to KD:ER or ROCK:ER cells treated with GSK3β inhibitor 6-
bromoindirubin-39-oxime (BIO) (Meijer et al., 2004) (Figure 3E). These results show that ROCK
activation increased β-catenin transcriptional activity and target gene transcription, which could drive
interfollicular epidermal cell proliferation.
Immunofluorescence of ROCK-activated epidermis revealed re-distribution of β-catenin (red
fluorescence and red trace) from membrane to cytoplasm (red arrowheads) and nucleus (blue
arrowheads), compared to identically treated control K14-KD:ER mice (Figure 4A, B). In contrast, E-
cadherin (green fluorescence and green trace), which associates with β-catenin in adherens junctions
remained at the cell membrane (Figure 4A, B). An image processing macro (see Supplemental
Experimental Procedures) developed to quantify nuclear and cytoplasmic localization of β-catenin
immunofluorescence showed ~2-fold increase in nuclear β-catenin upon ROCK activation and 5-fold
elevation in total β-catenin relative to K14-KD:ER epidermis, consistent with β-catenin western blots of
epidermal lysates (Figure 4C). β-catenin positive cells were also found increased in ROCK-activated
epidermis by FACS analysis of dissociated cells (Figure 4D). Immunofluorescence of ROCK-activated
epidermis using an antibody against activated β-catenin (dephosphorylated at Ser37 and Thr41) (van
Noort et al., 2002) revealed that nuclear localized β-catenin is the activated form (Figure 4E), which
was associated with increased phosphorylation of GSK3β on Ser9 that blocks phosphorylation of
substrate such as β-catenin (Dajani et al., 2001). BAPN treatment to inhibit Lox activity and collagen
cross-linking reversed both the nuclear accumulation of active β-catenin and GSK3β phosphorylation (
Figure 4E). These results indicate that the epidermal hyperproliferation in ROCK-activated epidermis is
associated with Tcf/Lef transcriptional activity brought about by stabilization and activation of β-
catenin.
β-catenin deletion abolishes ROCK-induced epidermal hyperproliferation
To determine whether β-catenin mediates ROCK-induced hyperproliferation, we crossed K14-ROCK:ER
and K14-KD:ER mice onto a background homozygous for a conditional floxed β-catenin allele
(Ctnnb1 ) (Brault et al., 2001) and K14-driven Cre recombinase/ER fusion protein expression
(K14-Cre:ER) (Vasioukhin et al., 1999). K14-ROCK:ER; β-catenin ; K14-Cre:ER compound mutant
mice treated for 5 days with 4HT exhibited loss of β-catenin within the interfollicular epidermis (
Figure 5A, S4A), which did not affect ROCK activation or LIMK activity, as shown by Mypt and cofilin
phosphorylation respectively (Figure S4B). β-catenin deletion blocked ROCK-induction of CD44v3-v10
or Cyclin D1 (Figure 5B, S4C). In the absence of β-catenin, ROCK activation did not induce epidermal
hyperproliferation as indicated by reduced Ki67 immunoreactivity or skin thickening (Figure 5C, S4D).
Indeed, β-catenin loss completely abolished ROCK-mediated skin thickening (Figure 5D) and
normalized Ki67 labeling (Figure 5E), but did not affect ROCK-induced collagen deposition (Figure 5F),
indicating that elevated collagen is not a consequence of β-catenin activation. β-catenin loss had no
effect on epidermal homeostasis in control K14-KD:ER mice (Figure S4E). Consistent with β-catenin
being a driver of epidermal proliferation, K14-Cre:ER, Ctnnb1  mice expressing a 4HT-
inducible version of constitutively active β-catenin (Harada et al., 1999) exhibited ~5-fold interfollicular
epidermal thickening associated with increased β-catenin (Figure 5G). These results indicate that ROCK
induced interfollicular epidermal hyperproliferation is β-catenin dependent, associated with increased
β-catenin transcriptional activity and expression of β-catenin regulated transcriptional targets, placing
ROCK activation and actomyosin-mediated cellular tension in a pathway leading to β-catenin
activation.
tm2Kem
Fl/Fl
tm1Mmt/+
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Actomyosin contractility is required for ROCK-induced epidermal proliferation
LIMK1 and LIMK2 are phosphorylated and activated by ROCK, and in turn phosphorylate and
inactivate the F-actin severing cofilin proteins (Scott and Olson, 2007). To determine whether
inhibiting mediators of actomyosin contractility would block ROCK induced epidermal
hyperproliferation, a selective and non-toxic LIMK inhibitor (LIMKi; compound 3 in (Ross-Macdonald
et al., 2008)), was applied in combination with 4HT. Staining with phospho-cofilin specific antibody
(Figure S5A) revealed that a single LIMKi treatment abolished cofilin phosphorylation (Figure S5B).
LIMKi application with 4HT for 5 days blocked skin thickening and ectopic interfollicular K6 in K14-
ROCK:ER mice (Figure 6A white arrows, Figure 6B, S5C), accompanied by absence of cofilin
phosphorylation (Figure 6A, Figure S5C) and reduced β-catenin levels (Figure 6A yellow arrow).
Similarly, inhibition of myosin ATPase activity to block actomyosin contraction with daily Blebbistatin
(Straight et al., 2003) application eliminated skin thickening, ectopic interfollicular K6 expression and
reduced β-catenin levels (Figure 6A, B). Lox inhibition with BAPN to reduce collagen cross-linking also
significantly reduced skin thickening (Figure 6B). LIMKi and Blebbistatin also reduced ROCK-induced
BrdU incorporation in 4HT treated K14-ROCK:ER skin to a level comparable to untreated K14-
ROCK:ER skin (Figure 6C), confirming that ROCK-induced hyperproliferation was reversed by
inhibition of actomyosin contractility. In primary cultured keratinocytes, Y27632 or LIMKi reduced
ROCK-induced BrdU incorporation to levels observed in untreated cells or 4HT treated control K14-
KD:ER keratinocytes (Figure S5D). ROCK induced collagen deposition also was significantly reduced by
LIMKi or Blebbistatin (Figure 6D). These observations indicate that interfollicular epidermal
hyperproliferation, β-catenin accumulation and collagen deposition following ROCK activation is
dependent upon sustained cellular tension mediated by actomyosin contractility.
β-catenin stabilization induced by integrin-responsive signaling pathway
Collagen is a major extracellular matrix protein that influences cellular behaviors by promoting integrin
clustering and activating downstream signaling (Egeblad et al., 2010), with FAK activation being an
early response (Zhao and Guan, 2009). FAK autophosphorylation at Tyr397 was elevated in 4HT
treated ROCK:ER skin relative to control KD:ER or WT skin (Figure 7A), while application of the
selective FAK inhibitor PF-562271 (Roberts et al., 2008) blocked FAK autophosphorylation (Figure 7A).
The PI3K/Akt axis has been shown to be important in FAK-mediated signaling downstream of
collagen-activated integrins (Tian et al., 2002). Akt phosphorylation on an activating Ser473 position
was elevated in ROCK-activated skin and reduced by topical application of FAK inhibitor PF-562271 (
Figure 7B). Akt phosphorylates GSK3β on Ser9, thereby creating a competitive pseudosubstrate that
blocks substrate phosphorylation (Dajani et al., 2001). ROCK activation increased GSK3β Ser9
phosphorylation relative to control 4HT-treated WT or KD:ER skin (Figure 7C), accompanied by
decreased β-catenin phosphorylation on GSK3β sites Ser37 and Thr41 (Figure 7C). Both increased
inhibitory GSK3β inhibitory Ser9phosphorylation and decreased β-catenin Ser37 and Thr41
phosphorylation were reversed by FAK inhibitor PF562271 (Figure 7C). In support of a FAK >
PI3K/AKT > GSK3β pathway being responsible for β-catenin regulation, the increased levels of β-
catenin and skin thickening in ROCK activated skin were blocked by FAK inhibitor PF562271 (
Figure 7D, 7E).
ROCK promotes papillomagenesis
To test the effect of cellular tension on tumor growth and progression, we examined how ROCK-
activation influenced skin tumors in a 2-stage chemical carcinogenesis protocol. Syngeneic papillomas
are induced in FVB/N mice by one application of the mutagen dimethylbenz[a]anthracene (DMBA)
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followed by repeated applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) (Hennings et al.,
1993). Papillomas arise and reproducibly convert at low frequency to invasive carcinomas by a
mechanism involving H-Ras mutations and MAP-kinase activation (Balmain et al., 1984; Quintanilla et
al., 1986). Tumors produced by this procedure model human SCC and have been used to determine the
dependence on genes such as beta;-catenin (Malanchi et al., 2008).
K14-ROCK:ER or K14-KD:ER mouse cohorts backcrossed at least 10 generations onto the FVB/N
background were treated twice weekly with vehicle or 4HT in addition to DMBA/TPA for a total of 15
weeks (Figure 8A), at which point carcinomas were observed and the experiment halted. Significantly
increased papillomas were observed in 4HT-treated K14-ROCK:ER mice compared to 4HT or vehicle-
treated K14-KD:ER mice or vehicle-treated K14-ROCK:ER mice (Figures 8B, S6A). A shift towards
larger papillomas (Figure 8C) and increased papilloma incidence (Figure 8B) resulted in a significantly
greater total papilloma burden (a function of papilloma volume and number) in 4HT-treated K14-
ROCK:ER mice relative to vehicle-treated control and to both K14-KD:ER treatment groups (Figure 8D
). Only the ROCK-activated cohort had papilloma to carcinomas conversion within 15 weeks (Figure 8D
). SHG analysis of epidermal collagen revealed significantly higher levels in the keratinocyte layer
associated with resident papillomas (Figure 8E). Total and nuclear β-catenin were significantly
increased in 4HT treated K14-ROCK:ER papillomas compared to 4HT treated K14-KDK:ER papillomas,
consistent with the increased tumor growth (Figure 8F, S6B). These results show that sustained ROCK
activation is sufficient to elevate collagen, activate β-catenin and increase papilloma incidence, growth
and progression to carcinoma.
The selective ROCK inhibitor Y27632 (Uehata et al., 1997) was used to reduce Rock signaling during
DMBA/TPA-induced papillomagenesis. Y27632 treatment of DMBA/TPA treated FVB/N mice markedly
reduced pMypt levels within hyperproliferative skin and papillomas (Figure S6C), confirming tissue
penetration and Rock inhibition. Pure FVB/N cohorts treated with Y27632 (Figure 8G) twice weekly
during the DMBA/TPA procedure developed significantly fewer (Figures 8H, S6C) and smaller
papillomas (Figure 8I) than control vehicle treated mice, resulting in significantly reduced tumor
burden (Figure 8J). Papilloma to carcinoma conversion rate was 6.5% was in the DMBA/TPA-treated
cohort, but only 1.5% in the cohort co-administered Y27632 within the 20 week treatment course (
Figure 8J). Collagen levels were significantly reduced in the keratinocyte layer associated with resident
papillomas as determined by SHG (Figure 8K). Y27632 treated papillomas also exhibited significantly
lower Cyclin D1 and Ki67 histoscores compared to vehicle treated papillomas (Figure S6D). Total as
well as nuclear β-catenin was significantly reduced in Y27632 treated papillomas, consistent with the
reduced tumor growth (Figure 8L, S6E). These results show that Rock inhibition lowered epidermal
collagen, reduced papillomagenesis and delayed tumor growth and progression by reducing
proliferation, indicating that actomyosin-mediated cellular tension makes crucial contributions to
tumor promotion.
Human skin tumors exhibit elevated ROCK expression and activity
To determine whether ROCK signaling was altered in human skin cancers, immunohistochemical
analysis of a tissue microarray derived from 40 cases of human squamous skin carcinomas was carried
out with a pan-specific ROCK1/2 antibody (Figure S6F) and a phospho-specific antibody for the ROCK
substrate MYPT as an indicator of ROCK activation. Most skin tumors analyzed (90%) expressed high
ROCK levels relative to phenotypically normal skin (Table S1, Figure S6G). Positive pixel analysis of
SCC samples revealed statistically significant increases in ROCK and pMYPT relative to normal skin
samples (Figure 8M), and MYPT phosphorylation correlated significantly with ROCK expression (
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Figure 8N). These results show that ROCK over-expression correlates with ROCK activation and is a
common occurrence in human SCC, suggesting that ROCK activation drives cellular tension to promote
human skin cancer. However, pMYPT staining indirectly correlates with MLC2 phosphorylation and
actomyosin contractility and as a consequence, inferences should be treated with some caution.
Discussion
Collagen, a major component of the extracellular matrix, may be increased in density as well as in post-
translational modifications that alter the structure and organization of collagen fibers, contributing to
variations in tissue stiffness (Egeblad et al., 2010). Cells grown in vitro on stiff collagen matrices have
been shown to activate Rho and ROCK signaling leading to increased actomyosin contractility, which
generates counter-balancing cellular tension in an attempt to balance internal and external forces
(Paszek et al., 2005; Wozniak et al., 2003) in a process dubbed “mechanoreciprocity” (Butcher et al.,
2009). In addition to this outside>inside signaling, there is evidence from cell-based experiments that
ROCK-mediated actomyosin contractility inside the cell may, conversely, reorganize extracellular matrix
structures or stimulate increased matrix protein synthesis and secretion (Butcher et al., 2009; Discher
et al., 2005; Huang and Ingber, 2005; Provenzano et al., 2008; Wozniak et al., 2003).
We now show that the conditional-activation of ROCK, the principal driver of actomyosin contractility
and cellular tension via MYPT and MLC phosphorylation (Figure 1A) (Samuel et al., 2009a), in murine
epidermis results in significant modification of the extracellular matrix through increased collagen
deposition leading to increased tissue stiffness. Accompanying the increased tissue stiffness, activation
of the mechanically-responsive β-catenin transcriptional co-activator promotes target gene
transcription and increased epidermal cell proliferation. These results show that the development of
cellular tension profoundly affects the external microenvironment and influences tissue homeostasis.
It has long been observed that tumor development is associated with increased tissue stiffness. In fact,
cancers such as mammary tumors are often detected by palpation or elastography of the abnormally
rigid tissue that surrounds them. Increased stiffness of the cellular microenvironment contributes
significantly to tumor cell survival, proliferation and progression (Egeblad et al., 2010). During the
course of tumor growth and progression, the tissue microenvironment undergoes significant
remodeling, which increases the mechanical forces that cancer cells are subjected to evoking
compensatory responses via Rho and ROCK activation (Butcher et al., 2009). Results from the present
study also show that this relationship is reciprocal; increased ROCK-induced cellular tension in vivo
causes alterations in the extracellular matrix and increased tissue stiffness. An important question is
whether the increased tissue stiffness induced by elevated cellular tension is sufficient to promote
tumor growth and progression. The results from our study show that conditional ROCK activation and
consequent increase in collagen deposition did indeed increase tumor growth and progression, while
ROCK inhibition reduced these responses. Therefore, in addition to external tissue-level forces
modulating cellular responses, mechanical alterations at the cellular-level can influence tissue
mechanoproperties that promote cancer. It has generally been assumed that the increased Rho and
ROCK activity commonly observed in cancer cells reflects a role in promoting invasion and metastasis
(Olson and Sahai, 2009). However, results from this study indicate that altered expression and/or
activity of actomyosin regulators may promote tumor growth by influencing the tumor
microenvironment. Therefore, in addition to ROCK inhibition, targeting proteins such as LIMK and
myosin that work downstream of ROCK in the regulation of the actomyosin cytoskeleton may have anti-
tumor therapeutic benefits by counteracting the effects of cellular tension on the microenvironment.
While our studies clearly show a role of actomyosin contractility in generating increased tissue stiffness
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via collagen deposition, further work will be required to determine the relative contributions of tumor
and tumor-associated cells such as stromal fibroblasts.
Mechanical regulation of β-catenin has been well documented in bone, a tissue often subjected to
continuous and repeated strain. Here, mechanical factors lead to β-catenin stabilization and nuclear
translocation, which is associated with the activation of a FAK > PI3K/Akt > GSK3β phosphorylation
cascade (Case and Rubin, 2010; Santos et al., 2010), in agreement with the observations in mouse skin.
Mechanical activation of the Drosophila β-catenin homologue armadillo as a result of tissue-level forces
has also been reported (Desprat et al., 2008). Increased β-catenin levels and concentration in
cytoplasmic/nuclear compartments have been reported in human cutaneous SCC tumors (Malanchi et
al., 2008; Papadavid et al., 2002), consistent with the results in hyperproliferative murine skin (
Figure 4). Interestingly, nuclear β-catenin levels are often elevated at the host-tumor interface of
invasive colorectal carcinomas (Brabletz et al., 2005). These areas would be predicted sites of elevated
mechanoresistance leading to increased external forces and consequently sites of high compensatory
Rho/ROCK activation. It would also follow that, in contrast to hard-wired genetic or epigenetic
alterations, these relatively acute mechanical responses to external tension contribute to the
transdifferentiation potential of tumor cells and promote adaptability of tumors to continuously
evolving microenvironmental factors, for instance during the process of metastasis.
EXPERIMENTAL PROCEDURES
Cell Culture
Primary keratinocytes were extracted from tail skin as described (McLean et al., 2001). Cells were
maintained at 37°C/5% CO /3% O , in keratinocyte growth medium (KBM-2; Clonetics) with
epidermal growth factor (10 ng/ml), insulin (5 μg/ml), hydrocortisone (0.5 μg/ml), bovine pituitary
extract protein (70 μg/ml) and 50 μM Ca  on collagen-1 coated dishes (Becton Dickinson).
Clonogenic survival assays
Primary keratinocytes were seeded on dishes coated with 0.9% agarose/DMEM (containing 10% FBS, L-
glutamine and antibiotics) at 2×10  cells/well in DMEM containing 0.45% agarose ± 1 μM 4HT and
maintained at 37 °C/10% CO . DMEM±1 μM 4HT was added to each well twice weekly. Two weeks
post-seeding, colonies >80 μm in diameter were scored from 5 fields/well.
Human Tissue Microarrays
Human TMAs were purchased from Protein Biotechnologies, which confirms that all tissue samples
were collected under strict IRB approved guidelines/protocols with informed consent. All collected
human tissues were treated under strict confidentiality and according to appropriate applicable laws
that protect the confidentiality of personal information. No names or any other identity information
were revealed during the development of tissue arrays, nor to end users, and as a result are exempt
from consideration by the Beatson Institute Committee on Human Subjects in Medical Research due to
being anonymized and non-traceable. CRUK guidelines were followed in the handling and analysis of
this material. TMAs containing tumor tissue and normal cores from 40 cases of squamous skin cancer
were baked for two hours at 60°C prior to immunohistochemistry.
Mice
K14-ROCK:ER mice were described previously (Samuel et al., 2009a). TOPGAL [Tg(Fos-lacZ)34Efu/J]
mice were from Jackson Labs. All procedures were performed under appropriate licenses and according
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to the UK Home Office guidelines.
In vivo gene induction and/or activation and enzyme inhibition
4-hydroxytamoxifen (4HT, Sigma, 1mg) in ethanol (100 μl) was applied to shaved dorsal skin and
repeated daily for up to 30 days. Inhibitors (per mouse, Blebbistatin–23μg; Y27632–25μg; LIMKi–
32μg; PF-562271–160μg; BAPN–760μg) were applied topically once daily for 5 consecutive days in
appropriate vehicle.
Keratinocyte extraction for western and FACS
Epidermal tissue was separated as previously described (Nowak and Fuchs, 2009). Epidermal cells
were lysed in 1 × RIPA buffer for western analysis, Trizol (Invitrogen) for mRNA extraction or fixed in
4% paraformaldehyde for FACS analysis using standard methods. All FACS analyses were carried out by
first gating K14 positive cells.
Chemical carcinogenesis
Chemical carcinogenesis was carried out as described (Quintanilla et al., 1986). DMBA (Sigma, 25 μg)
in acetone (150 μl) was applied directly to shaved dorsal skin. After three days, TPA (Sigma, 6.25 μg)
was applied in acetone (150 μl) and repeated twice weekly for 20 weeks or until a carcinoma developed.
Papillomas were counted and measured weekly. Final papilloma burden was calculated by summing the
individual products of papilloma number and the square of each papilloma diameter, which was then
normalized across cohorts against the K14-KD:ER average. Carcinoma conversion rate was calculated
as percentage of carcinomas observed relative to total number of papillomas.
Histology and immunohistochemistry
Histology and immunohistochemistry were performed as described (Samuel et al., 2009b). Antigen
retrieval buffer and antibody dilutions used appear in Supplemental Experimental Procedures. Slides
were imaged using a Hamamatsu Nanozoomer NDP slide scanner (Hamamatsu Photonics) and Digital
Slide Server (Slidepath) software.
Elastic Modulus Measurements and collagen staining
The mechanical properties of fresh frozen skin (Foutz et al., 1992) were assayed using an MFP3D-Bio
inverted optical AFM mounted on a Nikon TE2000-U inverted phase microscope (Asylum Research).
Pyramidal Si N  cantilevers with a manufacturer spring constant of 0.06N/m fitted with 5 μm
borosilicate glass microspheres (Novascan Tech) were calibrated using the thermal noise method
(Hutter and Bechhoefer, 1993) prior to AFM indentation. Force maps were acquired by sample
indentation with a force of 5nN. The Hertz model of impact (Hertz, 1881) was used to calculate the
Young’s elastic modulus of resulting force curves. Heat maps were generated using Igor Pro 6
(Wavemetrics). Picrosirius Red staining was carried out as described (Levental et al., 2009; Paszek et
al., 2005).
Acquisition of second harmonic generation (SHG) data from collagen
Samples of depilated and freshly excised skin were imaged using a 20× 0.95 NA water immersion
objective on an inverted Nikon TE-2000 microscope body. The excitation source was a Ti:Sapphire
femto-second laser cavity (Coherent Chameleon Ultra II), coupled into a LaVision Biotec Trim-scope
scan-head. 890 nm excitation wavelength was used to simultaneously collect SHG signal (435±20 nm)
from collagen and auto-fluorescence (525±25 nm) from surrounding tissue. Signal was acquired from
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three separate volumes measuring 500 × 500 × 200 μm across each sample, in steps of 2 μm imaging
depth, with an acquisition time of 30 minutes per volume.
Analysis of SHG signal from collagen
ImageJ was used to calculate percentage area covered by SHG signal per optical slice within a volume,
after conversion to a binary image based upon a manually determined threshold value. Results were
expressed as median ± SEM across all data sets for each genotype. A Grey Level Contrast Matrix
(GLCM) analysis was performed upon optical slices at which maximum coverage was observed for each
phenotype using the USB GLCM plug-in for ImageJ. The shown parameters were calculated for varying
pixel displacement values. Results were expressed as average ± SEM for each parameter for all
genotypes.
Statistical analysis
Unless indicated, statistical significance was determined by Student’s t-test. Data are shown as means ±
SD unless indicated. Box and whisker plots show medians and quartiles with p-values calculated using
Mann-Whitney test for comparing medians. In all cases, p<0.05 was used as significance cut-off.
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ROCK activation increases epidermal tissue stiffness and the density and depth of collagen deposition
within the skin
(A) Western blot shows Mlc2 Ser19phosphorylation in 4HT treated WT, KD:ER and ROCK:ER keratinocytes.
Immunohistochemical analyses show pMypt1 staining in 4HT or Vehicle treated WT, KD:ER and ROCK:ER skin.
(B) AFM Force maps of 4HT treated WT and ROCK:ER skin areas enclosed by yellow square as well as picrosirius red
staining viewed through parallel or orthogonally polarizing filters.
(C) Quantification of Young’s elastic Modulus and % area threshold of collagen in 4HT treated WT and ROCK:ER skin.
(D) Maximum projections along three axes of SHG collagen signal from representative 500 μm × 500 μm × 200 μm
volumes of 4HT treated WT and ROCK:ER skin. Red double headed arrows show relative thicknesses of collagen layer in
4HT treated WT and ROCK:ER skin.
(E) Graphs of collagen coverage values derived from SHG signal by depth (line graph) and at peak value (histogram
inset), measured over three tissue volumes each from three mice per cohort. Results are mean ± SEM.
Scale bars, 100μm
See also Figure S1 and Movies S1, S2 and S3.
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ROCK activation within murine skin causes epidermal hyperplasia
(A) Hemotoxylin and eosin (H&E) stained skin sections derived from 4HT-treated WT, KD:ER and ROCK:ER mice.
Change in ROCK:ER interfollicular epidermis thickness (arrows) compared to WT and KD:ER skin following five daily
topical 4HT treatments is shown in histogram. Measurements were made over five fields with three measurements taken
per field. Scale bars, 20μm
(B) BrdU incorporation in skin sections derived from 4HT-treated WT, KD:ER and ROCK:ER mice. Histogram shows
number of BrdU-labeled cells per mm basement membrane (BM) following 4HT treatment. Scale bars, 50 μm.
(C) Histogram shows fold change in number of colonies formed in soft agar by 4HT-treated ROCK:ER keratinocytes
relative to KD:ER keratinocytes. Representative fields of colonies are shown. Scale bars, 100 μm.
(D) K1, K6 and K14 expression in skin sections derived from 4HT-treated WT, KD:ER and ROCK:ER mice, without or
with BAPN treatment to inhibit lysyl oxidase. Scale bars, 100μm. Histogram shows percentage K6 positive cells within
epidermis derived from 4HT-treated WT, KD:ER and ROCK:ER mice as measured by FACS (See Figure S2C for profiles).
See also Figure S2
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ROCK activation in the murine epidermis is associated with Tcf/Lef target gene activation
(A) Expression of CD44 variants v3 and v3-v10 in 4HT-treated KD:ER and ROCK:ER skin by immunofluorescence. Scale
bars indicate 100 μm. Histogram shows CD44v3 mRNA expression within WT, KD:ER and ROCK:ER epidermis.
(B) Cyclin D1 expression in 4HT-treated ROCK:ER (arrow) and KD:ER skin. Histogram shows Cyclin D1 mRNA
expression within WT, KD:ER and ROCK:ER epidermis.
(C) Ectopic expression (yellow arrows) of Lgr5 promoter-driven EGFP:Cre within interfollicular epidermis in 4HT-
treated KD:ER and ROCK:ER skin. Boxed areas are enlarged in insets. Histogram shows Lgr5 mRNA expression within
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WT, KD:ER and ROCK:ER epidermis.
(D) Fresh-frozen skin from 4HT-treated TOPGAL mice on KD:ER and ROCK:ER backgrounds in which β-Galactosidase
activity was visualized using fluorescein di-galactoside. A red filter has been added to monochromatic channel to aid
visualization.
(E) Tcf/Lef transcriptional activity in ex vivo cultured KD:ER and ROCK:ER keratinocytes assayed using TOPFlash
reporter assay. GSK3β inhibitor BIO was used as positive control.
See also Figure S3
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β-catenin is stabilized and relocalized upon ROCK induction within the interfollicular epidermis
(A) Confocal slice showing β-catenin (red) and E-cadherin (green) distribution in 4HT-treated KD:ER and ROCK:ER
skin.
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(B) Pixel intensity of red (β-catenin), green (E-cadherin) and blue (DAPI) fluorescence measured along red arrows in
Figure 4A to assess co-localization. Membrane and nuclear regions are denoted. Red fluorescence is observed within
cytoplasm (red arrowheads) and nucleus (blue arrowheads) in 4HT treated ROCK:ER but not KD:ER skin.
(C) Pixel intensity of nuclear or total β-catenin staining in 4HT treated KD:ER and ROCK:ER skin sections.
Measurements were carried out on 5 fields each of sections derived from three mice per genotype. Western analysis
shows β-catenin protein level in pooled epidermal lysates from 4HT treated KD:ER and ROCK:ER mice (3 mice per
genotype).
(D) FACS of β-catenin staining versus forward scatter of epidermal cells derived from WT, KD:ER and ROCK:ER skin.
Histogram shows percentage β-catenin positive cells in each sample.
(E) Unphosphorylated (Ser37/Thr41)-β-catenin (red) and phosphorylated (Ser9) GSK3β (green) distribution in 4HT
treated KD:ER and ROCK:ER skin, either without or with BAPN treatment to inhibit lysyl oxidase.
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ROCK induced epidermal hyperproliferation is β-catenin dependent
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Vehicle or 4HT-treated β-catenin ; K14-Cre:ER mice expressing KD:ER or ROCK:ER as indicated were stained or
scored for:
(A) β-catenin
(B) β-catenin target genes CD44 (top panels) and Cyclin D1 (bottom panels).
(C) Ki-67 (top panels) and H&E (bottom panels). Skin thickness differences are indicated by white arrow pairs in H&E
panels.
(D) Skin thickness
(E) Ki67 positive cells per mm basement membrane
(F) Collagen area coverage by SHG
(G) K14-Cre:ER, Ctnnb1  mice were treated as indicated with vehicle or 4HT to activate β-catenin. Panels show
β-catenin staining and skin thickness (arrows); histogram indicates fold change in skin thickness.
Scale bars, 100 μm.
See also Figure S4
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ROCK induced epidermal hyperproliferation is dependent on actomyosin contractility
(A) Skin sections from ROCK:ER mice treated with Vehicle or 4HT, 4HT+LIMKi or 4HT+Blebbistatin, stained with H&E
or for K6, K14, β-catenin or pCfl. Scale bars indicate 100 μm.
(B) Fold change in ROCK:ER skin thickness relative to KD:ER skin following 4HT treatment in absence or presence of
LIMKi, Blebbistatin or BAPN.
(C) BrdU incorporation scored as positive cells per mm BM from untreated, 4HT-treated 4HT+LIMKi or
4HT+Blebbistatin treated ROCK:ER skin.
(D) Collagen area coverage in ROCK:ER skin following 4HT treatment in absence or presence of LIMKi or Blebbistatin.
See also Figure S5
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FAK, Akt and GSK3β phosphorylation increased in ROCK-activated skin
WT, KD:ER and ROCK:ER skin treated with 4HT alone or 4HT plus FAK inhibitor PF-562271 stained for:
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(A) K14 (red) and FAK pTyr397 (green)
(B) K14 (red) and Akt pSer473 (green)
(C) GSK3β pSer9 (green) and unphosphorylated β-catenin Ser37/Thr41 (red)
(D) Total β-catenin (green)
(E) Fold change in ROCK:ER skin thickness relative to KD:ER skin following 4HT treatment in absence or presence of
FAK inhibitor PF-562271.
Scale bars, 100μm
See also Figure S6
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ROCK activation accelerates papilloma growth and progression
(A) Timeline of 15 week chemical carcinogenesis and ROCK activation in cohorts of 6 mice of ROCK:ER and KD:ER
genotypes. Treatments were: orange arrow – DMBA, black arrows – TPA, green arrows – 4HT or Vehicle. Papilloma to
carcinoma conversions in individual ROCK:ER mice denoted by red arrows.
(B) Box and whisker plot of DMBA/TPA-induced papillomas per mouse in ROCK:ER and KD:ER mice treated with
vehicle or 4HT as indicated.
(C) Pie charts of papilloma size distribution at completion of 15 week treatment period in ROCK:ER and KD:ER mice
treated with vehicle or 4HT as indicated. Carcinomas are not included.
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(D) Histogram of DMBA/TPA papilloma burden and carcinoma conversion rate in ROCK:ER and KD:ER mice treated
with vehicle or 4HT as indicated.
(E) Collagen area coverage measured by SHG in 4HT treated KD:ER or ROCK:ER skin.
(F) Pixel intensity of nuclear or total β-catenin staining in 4HT treated KD:ER or ROCK:ER DMBA/TPA papillomas.
Measurements were carried out on 7 fields per condition.
(G) Timeline of 20 week chemical carcinogenesis and ROCK inhibition in cohorts of 6 WT FVB/N mice. Treatments
were: orange arrow – DMBA, black arrows – TPA, grey arrows – Y27632 or Vehicle. Papilloma to carcinoma conversion
events are denoted by red arrows.
(H) Box and whisker plot of DMBA/TPA-induced papillomas per mouse in vehicle or Y27632 treated WT FVB/N mice.
(I) Pie charts of papilloma size distribution at completion of 20 week treatment period in Y27632 or vehicle treated WT
FVB/N mice. Carcinomas are not included.
(J) Histogram of DMBA/TPA papilloma burden and carcinoma conversion rate in vehicle or Y27632 treated WT FVB/N
mice.
(K) Collagen area coverage measured by SHG in DMBA/TPA treated skin along with vehicle or Y27632.
(L) Pixel intensity of nuclear or total β-catenin staining in vehicle or Y27632 treated DMBA/TPA papillomas.
Measurements were carried out on 7 fields per condition.
(M) Results of positive pixel analyses of ROCK expression and MYPT phosphorylation in a sample of 40 human
epidermal squamous cell carcinomas.
(N) Correlation curve of pMYPT and ROCK positive pixel analyses. The 95% confidence interval is denoted by dotted
lines. Statistical significance was calculated using Chi-square test. A Pearson product-moment correlation coefficient (r)
of 0.7 confirms a large correlation between ROCK and pMYPT positive pixels.
See also Table S1
